咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Robot-assisted endoscopic ingu... 收藏

Robot-assisted endoscopic inguinal lymphadenectomy:A review of current outcomes

作     者:Gilberto Jose´Rodrigues Giuliano Betoni Guglielmetti Marcelo Orvieto Kulthe Ramesh Seetharam Bhat Vipul R.Patel Rafael Ferreira Coelho 

作者机构:Sao Paulo State Cancer InstituteUniversity of Sao Paulo School of MedicineSao PauloBrazil Clı´nica AlemanaSantiagoChile Department of UrologyAdventHealth Global Robotics InstituteCelebrationFLUnited States 

出 版 物:《Asian Journal of Urology》 (亚洲泌尿外科杂志(英文))

年 卷 期:2021年第8卷第1期

页      面:20-26页

核心收录:

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主  题:Penile tumor Minimally invasive surgery Robotic-assisted inguinal lymphadenectomy 

摘      要:Objective:To review the role of robot-assisted endoscopic inguinal lymphadenectomy(RAIL)in the management of penile ***:A PubMed search for all relevant publications regarding RAIL series up until August 2019 was performed using the keyword“robotic,“inguinal lymph node dissection,and“penile cancer.Weighted mean was calculated in the largest series for all outcomes using the number of patients included in each study as the weighting ***:We identified 23 articles,of note the three largest series that included 102,27,and 20 RAIL in 51,14,and 10 patients,*** vein was spared in 88.93%of RAIL cases in these series and node yield was 11.42 per groin;35.28%of patients had positive pathological *** weighted mean of operative time was 87.98 min per RAIL and the estimated blood loss was 37.08 mL per *** mean length of hospital stay was 1.29 days and the drain was kept in place for 17.02 days;the major complication rate was only 5.31%in these *** mean follow-up was 33.46 months with a recurrence-free survival of 96.33%.Conclusion:The literature regarding RAIL describes promising results,although it has shorter follow-up and higher costs when compared to historically series from the open *** series reported lower cutaneous complications compared to conventional approach,without compromising oncological ***,long-term results and larger trials are crucial to validate those findings.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分